While I'm watching the Green Bay Packers poised for a continued run of 7-1 (they haven't won 8 straight since Vince Lombardi) and scouring through weekend research, I'm impressed by the recent strength in Salesforce.com (NYSE: CRM). But what I think is even more interesting is that I don't think this puppy is done going up.
Salesforce provides Software as a Service (SaaS), hosted software that runs sales teams for thousands of companies. Instead of buying the software (like shelling out $300+ for Microsoft (NASDAQ: MSFT) Office), Salesforce "rents" the software via a subscription model. Salesforce has seen strong take-up of their service, with growth of 60% in 2007 and 58% in 2006. Even bullish analysts have projected subscription growth slowing down significantly over the next two years. Growth is definitely slowing -- but it's not going away. Look for more possible upside here.
Margins should also stand to benefit. As growth stabilizes, business will shift from first-time customers to renewals. Renewals are typically higher margin than first sales, given the lower associated sales cost.
High-flying tech companies eventually face slowing growth, but it generally doesn't happen overnight. For now, it looks like CRM has some more powder in its keg.
Zack Miller is the lead equity analyst for America Israel Investment Associates, LLC., the managing editor of IsraelNewsletter.com and a former equity analyst for a leading multinational hedge fund. He holds no position in CRM as of 11/04/07.
Last updated: February 13, 2012: 05:28 PM
Hot Stocks
DailyFinance Headlines
- Valentine's Day Romance ... With a Side of Fries
- 5 Things to Watch This Week: Cars, Games, Hearts, and a Lot of Z's
- 3 Keys to a Great Balance Transfer Card (and 1 Card That Offers Them)
- Is It Already 'The End' for E-Book Readers?
- Retail Stocks Are for Suckers: Why Their Rally Won't Last
Benzinga Headlines
- Military Budget Cuts Hit These Contractors
- Earnings Preview: Tesla Hoping to Retain its Drive
- Airlines the Latest to Suffer Euro Crisis Blues
- Internet-Hungry Consumers Force Vodafone to Consider a C&W Offer
- Seven Japanese Stocks Up More Than 10% Year to Date
TheFlyOnTheWall.com Headlines
- Skilled Healthcare sees FY12 EPS 78c-85c vs. consensus 78c
- Spanish Broadcasting regains compliance with NASDAQ
- Skilled Healthcare reports Q4 adjusted EPS 19c vs. consensus 15c
- Barrett Business Services reports Q4 EPS 41c vs. consensus 40c
- TAL International announces Q1 dividend of 55c per share
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- Ready to Invest in Your Love Life? For the Best ROI, Try a Niche Dating Site
- Valentine's Day Romance ... With a Side of Fries
- 5 Things to Watch This Week: Cars, Games, Hearts, and a Lot of Z's
- 3 Keys to a Great Balance Transfer Card (and 1 Card That Offers Them)
- Is It Already 'The End' for E-Book Readers?
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
5-Hour Energy: A Success Equal Parts Caffeine, Chemistry and…
Suddenly, Amazon Doesn't Love Its Moms Anymore

